BELOGAL

Pharmaceutical preparations, namely, anti-cancer preparations and preparations for treatment of central nervous system diseases, immune system disorders, metabolic diseases, lung diseases, and bacterial and fungal infections; pharmaceutical preparations for tissue targeting for the treatment of cancer, immune system disorders, central nervous system diseases, metabolic diseases, lung diseases, and bacterial and fungal infections; pharmaceutical preparations for controlled release of anti-cancer drugs and drugs for the treatment of immune system disorders, central nervous system diseases, metabolic diseases, lung diseases, and bacterial and fungal infections; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer, immune system disorders, central nervous system diseases, metabolic diseases, lung diseases, and bacterial and fungal infections; chemical preparations for medical purposes, namely, for the treatment of cancer, immune system disorders, central nervous system diseases, metabolic diseases, lung diseases, and bacterial and fungal infections; chemical preparations for veterinary purposes, namely, for the treatment of cancer, immune system disorders, central nervous system diseases, metabolic diseases, lung diseases, and bacterial and fungal infections in mammals; veterinary preparations for the treatment of cancer, immune system disorders, central nervous system diseases, metabolic diseases, lung diseases, and bacterial and fungal infections in mammals